Outlook Therapeutics prices $5M registered direct offering
Source: SeekingAlpha
2026-05-28 16:11:36 ET
More on Outlook Therapeutics
- Outlook Therapeutics announces $5M registered direct offering priced at-the-market
- Outlook Therapeutics stock slides after pricing $5M offering
- Seeking Alpha’s Quant Rating on Outlook Therapeutics
- Historical earnings data for Outlook Therapeutics
- Financial information for Outlook Therapeutics
Read the full article on Seeking Alpha
For further details see:
Outlook Therapeutics prices $5M registered direct offering
Outlook Therapeutics Inc.
NASDAQ: OTLK
OTLK Trading
26.41% G/L:
$0.8904 Last:
32,014,001 Volume:
$0.7446 Open:
OTLK Latest News
June 01, 2026 08:46:00 am
Outlook Therapeutics Announces Resubmission of Biologics License Application to U.S. FDA for ONS-5010/LYTENAVA(TM) (bevacizumab-vikg)
OTLK Stock Data
$32,307,405
71,451,190
1.63%
24
N/A
Biotechnology & Life Sciences
Healthcare
US
Iselin
